Acquired growth hormone resistance in adults

Bailliere's Clinical Endocrinology and Metabolism

Volumn 12, Issue 2, 1998, Pages 315-329

  Jenkins, R C ^a   Ross, R J M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Catabolism; Growth hormone; Insulin like growth factor 1

Indexed keywords

CYTOKINE; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BURN; CANCER; CLINICAL TRIAL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HALF LIFE TIME; HORMONE BINDING; HORMONE BLOOD LEVEL; HORMONE RESISTANCE; HORMONE SYNTHESIS; HUMAN; HYPOGLYCEMIA; INJURY; KIDNEY FAILURE; LIVER FAILURE; NEGATIVE FEEDBACK; NUTRITIONAL STATUS; PH; RECEPTOR DENSITY; REVIEW; SEPSIS;

EID: 0032407245     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(98)80025-6     Document Type: Article

References (71)

1. Abribat T Brazeau P Davignon I Garrel DR Insulin-like growth factor-I blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn Clinical Endocrinology 39 1993 583 589
2. Arnold J Campbell IT Samuels TA Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure Clinical Science 84 1993 655 661
3. Baruch Y Amit T Hertz P Decreased serum growth hormone-binding protein in patients with liver cirrhosis Journal of Clinical Endocrinology and Metabolism 73 1991 777 780
4. Behrman SW Kudsk KA Brown RO The effect of growth hormone on nutritional markers in enterally fed immobilised trauma patients Journal of Parenteral and Enteral Nutrition 19 1995 41 46
5. De Benedetti F Alonzi T Moretta A Interleukin-6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunded growth in children with chronic inflammation Journal of Clinical Investigation 99 1997 643 650
6. van den Berghe G De Zegher F Lauwers P Veldhuis JD Growth hormone secretion in critical illness: effect of dopamine Journal of Clinical Endocrinology and Metabolism 79 1994 1141 1146
7. Berneis K Keller U Metabolic actions of growth hormone: direct and indirect Baillière's Clinical Endocrinology and Metabolism 10 1996 337 352
8. Carlin K Carlin S A possible explanation for growth hormone resistance in chronic renal failure Medical Hypotheses 43 1994 193 194
9. Cotterill AM Mendel P Holly JMP The differential regulation of the circulating levels of the insulin-like growth factor binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery Clinical Endocrinology 44 1996 91 101
10. Cuneo RC Hickman PE Wallace JD Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease Clinical Endocrinology 32 1995 265 275
11. Cuthbertson DP Observations on the disturbance of metabolism produced by injury to the limbs Quarterly Journal of Medicine 2 1931 233 246
12. Cwyfan-Hughes SC Cotterill AM Molloy AR The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery Journal of Endocrinology 135 1992 135 145
13. Davenport ML Isley WL Pucilowska JB Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery Journal of Clinical Endocrinology and Metabolism 75 1992 590 595
14. Davies SC Wass JA Ross RJ The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness Journal of Endocrinology 130 1991 469 473
15. Donahue SP Philips LS Response of IGF-I to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status American Journal of Clinical Nutrition 50 1989 962 969
16. Douglas RG Humberstone DA Haystead A Shaw JHF Metabolic effects of recombinant human growth hromone: isotopic studies in the postabortive state and during total parenteral nutrition British Journal of Surgery 77 1990 785 790
17. Ellis KJ Lee PDK Pivarnik JM Changes in body composition of human immuno-deficiency virus-infected males receiving insulin-like growth factor I and growth hormone Journal of Clinical Endocrinology and Metabolism 81 1996 3033 3038
18. Fouque D Peng SC Kopple JD Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients Kidney International 47 1995 869 875
19. Fouque D Peng SC Kopple JD Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients Kidney International 47 1995 876 883
20. Frayn KN Price DA Maycock PF Carroll SM Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes Clinical Endocrinology 20 1984 179 187
21. Garcia-Mayor RVG Perez AJ Gandara A Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects Clinical Endocrinology 39 1993 337 343
22. Giudice LC IGF binding protein-3 protease regulation: how sweet it is! Journal of Clinical Endocrinology and Metabolism 80 1995 2279 2281
23. Gottardis M Benzer A Koller W Improvement of septic syndrome after administration of recombinant human growth hormone? Journal of Trauma 31 1991 81 86
24. Haffner D Schaefer F Girard J Metabolic clearance of recombinant human growth hormone in health and chronic renal failure Journal of Clinical Investigation 93 1994 1163 1171
25. Haffner D Tönshoff B Blum WF Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-liable subunit and growth hormone binding protein in nephrotic children Kidney International 52 1997 802 810
26. Hartman ML Veldhuis JD Johnson ML Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men Journal of Clinical Endocrinology and Metabolism 74 1992 757 765
27. Hawker FH Stewart PM Baxter RC Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients Critical Care Medicine 15 1987 732 736
28. Hermansson M Wickelgren RB Hammarqvist F Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery Journal of Clinical Endocrinology and Metabolism 82 1997 421 428
29. Hulting AL Hall K Werner S Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia Acta Endocrinologica 106 1984 305 310
30. Hung CH Kover K Moore WV Characteristics of somatotropic growth hormone binding to homologous liver plasma membranes Molecular and Cellular Endocrinology 39 1985 189 196
31. Isley WL Underwood LE Clemmons DR Dietary components that regulate serum somatomedin-C concentrations in humans Journal of Clinical Investigation 71 1983 175 182
32. Jacob V Le Carpentier JE Salzano S IGF-I, a marker of undernutrition in hemodialysis patients American Journal of Clinical Nutrition 52 1990 39 44
33. Jeevanandam M Ramias L Shamos RF Schiller WR Decreased growth hormone levels in the catabolic phase of severe injury Surgery 111 1992 495 502
34. Jenkins RC Ross RJM Growth hormone therapy for protein catabolism Quarterly Journal of Medicine 89 1996 813 819
35. Knox J Demling R Wilmore D Increased survival after major thermal injury: the effect of growth hormone therapy in adults Journal of Trauma 39 1995 526 530
36. Kupfer SR Underwood LE Baxter RC Clemmons DR Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by use of both agents simultaneously Journal of Clinical Investigation 91 1993 391 396
37. Lee PDK Pivarnik JM Bukar JG A randomized, placebo-controlled trial of combined insulin-like growth factor 1 and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection Journal of Clinical Endocrinology and Metabolism 81 1996 2968 2975
38. Lieberman SA Butterfield GE Harrison D Hoffman AR Anabolic effects of recombinant insulin-like growth factor-I in cachetic patients with the acquired immunodeficiency syndrome Journal of Clinical Endocrinology and Metabolism 78 1994 404 410
39. Maheshwari HG Rifkin I Butler J Norman M Growth hormone binding protein in patients with renal failure Acta Endocrinologica 127 1992 485 488
40. Mandrup-Poulsen T Nerup J Reimers JI Cytokines and the endocrine system. I. The immunoendocrine network European Journal of Endocrinology 133 1995 665 666
41. Melarvie S Jeevanadam M Holaday NJ Petersen SR Pulsatile nature of growth hormone levels in critically ill trauma victims Surgery 117 1995 402 408
42. Merimee TJ Zapf J Froesch ER Insulin-like growth factors in the fed and fasted states Journal of Clinical Endocrinology and Metabolism 55 1982 999 1002
43. Miell JP Taylor AM Jones J Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery Clinical Endocrinology 37 1992 542 551
44. Minuto F Barreca A Adami GF Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters Journal of Parenteral and Enteral Nutrition 13 1989 392 396
45. Murphy LJ Vrhovsek E Lazarus L Characterisation of specific growth hormone binding sites in mouse fibroblasts Endocrinology 113 1983 750 757
46. Musey VC Goldstein S Farmer PK Differential regulation of IGF-I and IGF-binding protein-1 by dietary composition in humans American Journal of Medical Science 305 1993 131 138
47. Phillips LS Unterman TG Somatomedin activity in disorders of nutrition and metabolism Clinical Endocrinology and Metabolism 13 1984 145 189
48. Postel-Vinay M-C Saab C Gourmelen M Nutritional status and growth hormone-binding protein Hormone Research 44 1995 177 181
49. Rabkin R Fervenza FC Maidment H Pharmacokinetics of insulin-like growth factor-I in advanced chronic renal failure Kidney International 49 1996 1134 1140
50. Rondanelli M Solerte SB Fioravanti M Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection Aids Research and Human Retroviruses 13 1997 1243 1249
51. Ross RJM Goodwin FJ Houghton BJ Boucher BJ Alteration of pituitary thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis Annals of Clinical Biochemistry 22 1985 156 160
52. Ross RJ Miell JP Holly JM Levels of GH binding activity, IGFBP-I, insulin, blood glucose and cortisol in intensive care patients Clinical Endocrinology 35 1991 361 367
53. Ross RJM Miell J Freeman E Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin like growth factor-I Clinical Endocrinology 35 1991 47 54
54. Ross RJ Chew SL D'Souza L Expression of IGF-I and IGF-binding protein genes in cirrhotic liver Journal of Endocrinology 149 1996 209 216
55. Sanaka T Shinobe M Ando M IGF-I as an early indicator of malnutrition in patients with end-stage renal disease Nephron 67 1994 73 81
56. Schaefer F Baumann G Haffner D Multifactorial control of the elimination kinetics of unbound (free) growth hormone in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma Journal of Clinical Endocrinology and Metabolism 81 1996 22 31
57. Snyder DK Underwood LE Clemmons DR Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent American Journal of Clinical Nutrition 52 1990 431 437
58. Tayek JA Brasel JA Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study Journal of Clinical Endocrinology and Metabolism 80 1995 2082 2087
59. Tayek JA Bulcavage L Chlebowski RT Relationship of hepatic glucose production to grwoth hormone and severity of malnutrition in a population with colorectal carcinoma Cancer Research 50 1990 2119 2122
60. Tönshoff B Blum WF Mehls O Serum of insulin-like growth factors and their binding proteins in children with end-stage renal disease Pediatric Nephrology 10 1996 269 274
61. Tönshoff B Mehls O Heinrich U Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease Journal of Pediatrics 116 1990 561 566
62. Tsigos C Papanicolaou DA Defensor R Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure Neuroendocrinology 66 1997 54 62
63. Vara-Thorbeck R Guerrero JA Rosell J Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on post-operative immune function World Journal of Surgery 17 1993 530 538
64. Voerman HJ Strack van Schijndel RJM Groeneveld ABJ Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens Metabolism 9 1992 934 940
65. Wilmore DW Catabolic illness. Strategies for enhancing recovery New England Journal of Medicine 325 1991 695 702
66. Wolf M Bohm S Brand M Kreymann G Proinflammatory cytokines interleukin 1 beta and tumour necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells European Journal of Endocrinology 135 1996 729 737
67. Woods KA Savage MO Laron syndrome: typical and atypical forms Baillière's Clinical Endocrinology and Metabolism 10 1996 371 387
68. Woods KA Camacho-Hubner C Savage MO Clark AJL Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor-I gene New England Journal of Medicine 335 1996 1363 1367
69. Wright AD Lowy C Fraser TR Serum growth hormone and glucose intolerance in renal failure Lancet ii 1968 798 801
70. Yarwood GD Ross RJM Medbak S Administration of human recombinant insulin like growth factor-1 to critically ill patients Critical Care Medicine 25 1997 1352 1361
71. Ziegler TR Rombeau JL Young LS Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study Journal of Clinical Endocrinology and Metabolism 74 1992 865 873